Cancer Gene Therapy
Harbin Medical University publishes research in cancer gene therapy
Published in Hospital Business Week, December 16th, 2007
Research findings, 'A20 inhibits human salivary adenoid cystic carcinoma cells invasion via blocking nuclear factor-kappaB activation,' are discussed in a new report. According to a study from Harbin, People's Republic of China, "A20, also known as tumor necrosis factor alpha induced protein 3 (TNFaip3), is a cytoplasmic zinc finger protein that inhibits nuclear factor kappa-B (NF-kappaB) activity and prevents tumor necrosis factor (TNF)-mediated programmed cell death. NF-kappaB is a transcription factor that regulates expression of genes involved in cell proliferation, cell survival and anti-apoptosis."
"Several studies have implicated that the NF-kappaB signal pathway...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Acute Myeloid Leukemia
St. Jude Researchers Identify Key Genetic Trigger of Acute Myeloid Leukemia - Addiction Medicine
VH1 Teams Up with Dr. Drew for 'Celebrity Rehab With Dr. Drew,' a Series Depicting the Process of Overcoming Addiction - Advancing Excellence in America's Nursing Homes
Stakeholders Gather to Share Nursing Home Quality Improvement Strategies - Adverse Drug Reactions
Vermont Requires Reporting of NQF Serious Reportable Events - AG Mednet
AG Mednet Enables Marlborough Hospital To Offer Advanced Imaging Capabilities, Enhance Range of Patient Services and Complete a PACS Migration Project - Alexian Brothers Hospital Network
New Study Shows More Than Half of All Americans are Unable to Access Vital Records Quickly During an Emergency - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
